Colorectal cancer (CRC) is a significant global health concern, with more than 500,000 European citizens diagnosed every year. As we observe Colorectal Cancer Awareness Month this March, it’s crucial to shine a spotlight on the importance of early detection and prevention strategies in combating this disease. At DIOPTRA, our mission is to revolutionize CRC screening by…
In the bustling city of Larissa, Greece, the 2024 Innovent Forum stirred excitement and anticipation among innovators, researchers, and industry leaders alike. Among the myriad of groundbreaking discussions and presentations, one stood out prominently – the discourse on personalised medicine and its intersection with medical informatics. At the forefront of this dialogue was Stavros Pitoglou…
On January 26th, DIOPTRA partner I2Grow participated to RƏvolution: The first Italian meeting on Social Media and Digitisation in Medicine, held at Istituto Europeo di Oncologia (IEO) in Milan. RƏvolution served as an inclusive and dynamic space where physicians, curious citizens, health professionals, scientists, communication experts (and many others) could share experiences, ideas and knowledge…
DIOPTRA participated in the Symposium on E-health Solutions for Cancer Patients and Their Caregivers last month. The event provided an essential opportunity for DIOPTRA to present the Horizon Europe project, which aims to provide groundbreaking new technologies to address colorectal cancer (CRC) risk assessment, screening, and progression. The event, which ran from January 10 to…
DIOPTRA project is thrilled to announce the launch of an ambitious new study designed to make early detection of colorectal cancer (CRC) more accessible and effective. The study will combine artificial intelligence (AI) and blood tests to identify the disease at its earliest stages, offering hope for more effective treatment and potentially saving lives. The…
The second plenary meeting of the DIOPTRA consortium took place on October 2nd and 3rd in Nicosia, Cyprus, hosted by the Institute of Communication & Computer Systems (ICCS). This important meeting charted the course for the upcoming phases of our project that aims to revolutionise colorectal cancer (CRC) screening and diagnostics through advanced technology. The…
On 5 September 2023, DIOPTRA’s sister project LUCIA (Understanding Lung Cancer related risk factors and their Impact Assessment) is organising a workshop on “Understanding Lung Cancer”. You can access the agenda and register here. The workshop will set up the scene of LUCIA project’s contributions in the next years to advance in risk modelling, prevention…
The ‘Predictive Risk Factors for Colorectal Cancer in the DIOPTRA Retrospective Study’ is a groundbreaking research endeavour aimed at understanding the variables strongly correlated with Colorectal Cancer (CRC). Spanning 34 months and involving over 5000 subjects, the study aims to identify early CRC risk through the meticulous analysis of data, employing both statistical methods and…
DIOPTRA, a new Horizon Europe project, aims to revolutionise Colorectal Cancer (CRC) screening via cutting-edge research towards a holistic, personalised and accessible method for early detection. The project plans to introduce an early screening and risk assessment solution for all citizens that considers risk factors and protein biomarkers to identify high-risk cases in need of…
